Piper Jaffray Upgrades Pacific Biosciences of California (PACB) to Neutral
Piper Jaffray upgraded Pacific Biosciences of California (NASDAQ: PACB) from Underweight to Neutral with a price target of $3.10 (from $2.00).
For an analyst ratings summary and ratings history on Pacific Biosciences of California click here. For more ratings news on Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $2.67 yesterday, with a 52 week range of $0.00-$0.00.
For an analyst ratings summary and ratings history on Pacific Biosciences of California click here. For more ratings news on Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $2.67 yesterday, with a 52 week range of $0.00-$0.00.